Warning Issued for Dishonest Removal of Amitriptyline by Pharmacist
Date of Decision: October 27, 2025
Registrant's Role: Pharmacist
Allegations:
- Removed three boxes of Amitriptyline 10mg tablets from the pharmacy shelf without a valid prescription, payment, or employer permission.
- Provided a misleading initial explanation for possession of the medication.
- Admitted to taking the medication without authorisation.
- Acted dishonestly in contravention of professional standards.
Outcome: Warning issued, published on the GPhC register for 12 months.
GPhC Standards Breached:
- Standard 6 – Behave in a professional manner: are trustworthy and act with honesty and integrity
- Standard 8 – Speak up when they have concerns or when things go wrong: are open and honest when things go wrong
Case Summary
Allegations
The case revolves around a pharmacist who, on 12 August 2024, removed three boxes of 28 Amitriptyline 10mg tablets from the pharmacy shelf without obtaining a valid prescription, making payment, or securing permission from her employer. This conduct was identified during an internal investigation after the medication was discovered in the registrant’s vehicle. Initially, the registrant claimed the medication belonged to her mother. However, upon further inquiry, she admitted to having taken the medication from the pharmacy without appropriate authorisation.
The core allegation centres on dishonest conduct, particularly given the deceptive initial explanation and the unauthorised removal of a controlled medication from the pharmacy’s stock. Although not classified under controlled drugs legally, Amitriptyline is a tricyclic antidepressant often used for conditions such as neuropathic pain or depression and is not freely accessible without proper authorisation due to its potential toxicity in overdose and associated risks.
Continue Reading the Full Case
This case was published more than two weeks ago. A premium subscription is required to read the complete case summary.
- Full allegations considered by the GPhC/PSNI
- Panel findings and reasoning
- Outcome of the investigation
- Sanctions considered and imposed on the Pharmacist
- Key professional learning points
Original Case Document
The original determination document is available to registered users.